We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Late outcome analysis of the Braile Biomédica® pericardial valve in the aortic position.
- Authors
Azeredo, Lisandro Gonçalves; Veronese, Elinthon Tavares; Duncan Santiago, José Augusto; de Almeida Brandão, Carlos Manuel; Alberto Pomerantzeff, Pablo Maria; Jatene, Fabio Biscegli
- Abstract
Objective: Aortic valve replacement with Braile bovine pericardial prosthesis has been routinely done at the Heart Institute of the Universidade de São Paulo Medical School since 2006. The objective of this study is to analyze the results of Braile Biomédica ® aortic bioprosthesis in patients with aortic valve disease. Methods: We retrospectively evaluated 196 patients with aortic valve disease submitted to aortic valve replacement with Braile Biomédica® bovine pericardial prosthesis, between 2006 and 2010. Mean age was 59.41±16.34 years and 67.3% were male. Before surgery, 73.4% of patients were in NYHA functional class III or IV. Results: Hospital mortality was 8.16% (16 patients). Linearized rates of mortality, endocarditis, reintervention, and structural dysfunction were 1.065%, 0.91%, 0.68% and 0.075% patients/year, respectively. Actuarial survival was 90.59±2.56% in 88 months. Freedom from reintervention, endocarditis and structural dysfunction was respectively 91.38±2.79%, 89.84±2.92% and 98.57±0.72% in 88 months. Conclusion: The Braile Biomédica® pericardial aortic valve prosthesis demonstrated actuarial survival and durability similar to that described in the literature, but further follow up is required to assess the incidence of prosthetic valve endocarditis and structural dysfunction in the future.
- Subjects
AORTIC valve transplantation; PROSTHETIC heart valves; PERICARDIUM surgery; AORTIC valve diseases; BIOPROSTHESIS; HEALTH outcome assessment; THERAPEUTICS
- Publication
Brazilian Journal of Cardiovascular Surgery, 2014, Vol 29, Issue 3, p316
- ISSN
0102-7638
- Publication type
Article
- DOI
10.5935/1678-9741.20140081